Year: 2018
Type: article
Abstract: Bariatric surgery is widely used to treat obesity and improves type 2 diabetes beyond expectations from the degree of weight loss. Elevated post-prandial concentrations of glucagon-like peptide 1 (GLP-1), peptide YY (PYY), and insulin are widely reported, but the importance of GLP-1 in post-bariatric physiology remains debated. Here, we show that GLP-1 is a major driver of insulin secretion after bariatric surgery, as demonstrated by blocking GLP-1 receptors (GLP1Rs) post-gastrectomy in lean humans using Exendin-9 or in mice using an anti-GLP1R antibody. Transcriptomics and peptidomics analyses revealed that human and mouse enteroendocrine cells were unaltered post-surgery; instead, we found that elevated plasma GLP-1 and PYY correlated with increased nutrient delivery to the distal gut in mice. We conclude that increased GLP-1 secretion after bariatric surgery arises from rapid nutrient delivery to the distal gut and is a key driver of enhanced insulin secretion.
Source: Cell Reports
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $5,555
Funders: AstraZeneca, Wellcome Trust, Cancer Research UK, National Institute for Health and Care Research, Royal College of Surgeons of England, Society for Endocrinology, European Foundation for the Study of Diabetes, Novo Nordisk, Evelyn Trust, Medical Research Council, NIHR Cambridge Biomedical Research Centre, Cancer Research UK Cambridge Institute, University of Cambridge, NIHR Sheffield Biomedical Research Centre, National Institute of Diabetes and Digestive and Kidney Diseases
Awards: G1041443218, G1045075726, G1801700879, UKDP: Integrated DEmentiA research environment (IDEA), Physiology of the Enteroendocrine System., G2595365970, Entero-endocrinology including the effects of bariatric surgery, G373495634, Institute of Metabolic Science., Transcriptional events controlling enteroendocrine cell differentiation, Enabling technologies, Institute of Metabolic Science., Innovative Technologies for Stratified and Experimental Medicine, Physiology of the Enteroendocrine System., G71816680, G7850449913, G905023109
OpenAlex ID: W2912094716
